statin-dependent qtl gatm expression associated statin-induced myopathy
statins prescribed widely lower plasma low-density lipoprotein ldl concentrations cardiovascular disease risk shown beneficial effects broad range patients however statins associated increased risk albeit small clinical myopathy type diabetes despite evidence substantial genetic influence ldl concentrations pharmacogenomic trials failed identify genetic variations large effects either statin efficacy- toxicity produced little information regarding mechanisms modulate statin response identify downstream target statin treatment screening effects vitro statin exposure genetic associations gene expression levels lymphoblastoid cell lines derived participants clinical trial simvastatin treatment analysis identified six expression quantitative trait loci eqtls interacted simvastatin exposure including rs9806699 cis-eqtl gene glycine amidinotransferase gatm encodes rate-limiting enzyme creatine synthesis found locus associated incidence statin-induced myotoxicity two separate populations meta-analysis odds ratio furthermore found gatm knockdown hepatocyte-derived cell lines attenuated transcriptional response sterol depletion demonstrating gatm may act functional link statin-mediated lowering cholesterol susceptibility statin-induced myopathy
